期刊
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY
卷 4, 期 3, 页码 241-245出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/157489209789206850
关键词
Amrubicin; small cell; lung cancer; chemotherapy; synthetic anthracyclin
Amrubicin is a synthetic anthracyclin analogue that has significant activity in Japanese patients with extensive stage small cell lung cancer (ES-SCLC). There has not been significant advances made in the treatment of this disease in last several years and new therapies are desperately needed to change the natural history of this disease. Preliminary data has shown that amrubicin possesses anti-tumor activity in patients with extensive stage small cell lung cancer in the western population. Clinical trials are on going to evaluate this agent further in Europe and US. If effective, it may be an invaluable addition into the current armamentarium to treat this deadly disease. The review includes patent coverage on the treatment of small cell lung cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据